Fukuyama M - Search Results

1

Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.

Murata M, Fukuyama M, Satoh K, Fujimura Y, Yoshioka A, Takahashi H, Handa M, Kawai Y, Watanabe K, Ikeda Y. Murata M, et al. Among authors: fukuyama m. J Clin Invest. 1993 Sep;92(3):1555-8. doi: 10.1172/JCI116735. J Clin Invest. 1993. PMID: 8376606 Free PMC article.

2

Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation.

Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, Fujimura Y, Fukuyama M, Handa S, Ogawa S. Goto S, et al. Among authors: fukuyama m. Circulation. 1992 Dec;86(6):1859-63. doi: 10.1161/01.cir.86.6.1859. Circulation. 1992. PMID: 1360339

3

Continuous measurement of shear-induced platelet aggregation.

Fukuyama M, Sakai K, Itagaki I, Kawano K, Murata M, Kawai Y, Watanabe K, Handa M, Ikeda Y. Fukuyama M, et al. Thromb Res. 1989 May 1;54(3):253-60. doi: 10.1016/0049-3848(89)90233-8. Thromb Res. 1989. PMID: 2501904

4

Shear-induced platelet aggregation in cerebral ischemia.

Uchiyama S, Yamazaki M, Maruyama S, Handa M, Ikeda Y, Fukuyama M, Itagaki I. Uchiyama S, et al. Among authors: fukuyama m. Stroke. 1994 Aug;25(8):1547-51. doi: 10.1161/01.str.25.8.1547. Stroke. 1994. PMID: 8042205 Clinical Trial.

5

Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation.

Ikeda Y, Handa M, Kamata T, Kawano K, Kawai Y, Watanabe K, Kawakami K, Sakai K, Fukuyama M, Itagaki I, et al. Ikeda Y, et al. Among authors: fukuyama m. Thromb Haemost. 1993 May 3;69(5):496-502. Thromb Haemost. 1993. PMID: 8391728

6

Change in intracellular calcium ions during shear induced platelet aggregation.

Kawakami K, Fukuyama M, Sakai K, Itagaki I, Kawano K, Handa M, Ikeda Y. Kawakami K, et al. Among authors: fukuyama m. ASAIO Trans. 1990 Jul-Sep;36(3):M696-9. ASAIO Trans. 1990. PMID: 2252786

7

Shear stress induces not only platelet aggregation but also platelet-tumor cell interaction.

Fukuyama M, Kawakami K, Sakai K, Itagaki I, Kawano K, Handa M, Ikeda Y. Fukuyama M, et al. ASAIO Trans. 1990 Jul-Sep;36(3):M189-91. ASAIO Trans. 1990. PMID: 2252655

8

Interaction of noradrenaline and dopamine in patients with essential hypertension or with pheochromocytoma.

Yoshimura M, Ikegaki I, Fukuyama M, Nishimura M, Takahashi H. Yoshimura M, et al. Among authors: fukuyama m. Clin Exp Hypertens A. 1989;11 Suppl 1:397-402. doi: 10.3109/10641968909045446. Clin Exp Hypertens A. 1989. PMID: 2743600

9

Comparison of nisoldipine and atenolol in the treatment of essential hypertension.

Takahashi H, Fukuyama M, Yoneda S, Okabayashi H, Yoshimura M. Takahashi H, et al. Among authors: fukuyama m. Arzneimittelforschung. 1989 Mar;39(3):379-82. Arzneimittelforschung. 1989. PMID: 2667523 Clinical Trial.

10

[Mechanism of resistance of Shigella flexneri 2a resistant to new quinolone antibiotics].

Oonaka K, Fukuyama M, Tanaka M, Sato K, Ohnishi K, Ajima I, Murata M. Oonaka K, et al. Among authors: fukuyama m. Kansenshogaku Zasshi. 1998 Apr;72(4):365-70. doi: 10.11150/kansenshogakuzasshi1970.72.365. Kansenshogaku Zasshi. 1998. PMID: 9621565 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters